摘要
血糖控制是延缓糖尿病进展及并发症的重要措施之一,但个体化的糖化血红蛋白(HbA1c)控制目标值在不同的患者究竟如何还存在分歧。为了满足中国糖尿病治疗工作的需要,中华医学会内分泌学分会组织相关专家,对中国成人2型糖尿病HbA1c控制目标提出了初步共识:不统一推荐成人2型糖尿病的HbA1c控制目标,从病情分层和社会因素的差异建议相对较合理的HbA1c值。强调血糖控制必须安全、可行、科学,坚持个体化原则,其中安全性最重要。同时强调血糖之外的其他血管病危险因素的控制也十分重要。
Summary： Glycemic control is one of the important treatments for delaying the progression and complications in diabetes, but divergences exist on the individual HbA1 c control target of different patients, A preliminary consensus on the HbAlc control target in adults with type 2 diabetes is proposed by experts of Chinese Society of Endocrinology（CSE）. Instead of recommending a general standard value for all patients,a reasonable target is suggested to satisfy the different conditions and social factors. Some important principles must be followed for the gly- cemic control,including safety, feasibility, scientificity and individualization ; among which, the most important one is safety. Besides, to control plasma glucose, we should pay equal attention to the other risk factors of vascular disease at the same time.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2011年第2期113-115,共3页
Chinese Journal of Practical Internal Medicine
